IDS/QIDS
Inventory of Depressive Symptomatology (IDS) and Quick Inventory of Depressive Symptomatology (QIDS)
Mobile Menu

REFERENCES

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington DC. 1994.
  2. Beck, A.T., Steer, R.A., Ball, R., Ranieri, W. Comparison of Beck Depression Inventories IA and II in psychiatric outpatients. Journal of Personality Assessment, 67(3): 588-597, 1996.
  3. Beck, A.T., Ward, C.H., Mendelson, M., Mock, J.E., and Erbaugh, J.K. An inventory for measuring depression. Archives of General Psychiatry, 4: 561-571, 1961.
  4. Biggs, M.M., Shores-Wilson, K., Rush, A.J., Carmody, T.J., Trivedi, M.H., Crismon, M.L., Toprac, M.G. and Mason, M. A comparison of alternative assessments of depressive symptom severity: A pilot study. Psychiatry Research, 96:269-279, 2000.
  5. Boyer, P., Tassin, J.P., Falissart, B., and Troy, S. Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression. Journal of Clinical Pharmacy and Therapeutics, 25(5):363-371, 2000.
  6. Brown, E.S., Khan, DA., Nejtek, V.A., Thomas, N.R. and Mahadi, S.F. Depressive symptoms and functioning in asthma patients. Primary Care Psychiatry, 6(4):155-161, 2001.
  7. Carpenter, L.L., Yasmin, S., Price, L.H. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biological Psychiatry, 51:183-188, 2002.
  8. Carroll, B.J., Feinberg, M., Smouse, P.E., Rawson, S.G., and Greden, J.F. The Carroll Rating Scale for depression, 1: Development, reliability and validity. British Journal of Psychiatry, 138:194-209, 1981.
  9. Corruble, E., Legrand, J.M., Duret, C., Charles, G. and Guelfi, J.D. IDS-C and IDS-SR: Psychometric properties in depressed in-patients. Journal of Affective Disorders, 56:95-101, 1999.
  10. Corruble, E., Legrand, J.M., Zvenigorowski, H., Duret, C. and Guelfi, J.D. Concordance between self-report and clinician's assessment of depression. Journal of Psychiatric Research, 33:457-465, 1999.
  11. Cronbach, L. J. Coefficient alpha and the internal structure of tests. Psychometrika, 16:297 - 309, 1951.
  12. Denicoff, K.D., Leverich, G.S., Nolen, W.A., Rush, A.J., McElroy, S.L., Keck, P.E., Suppes, T., Altshuler, L.L., Kupka, R., Frye, M.A., Hatef, J., Brotman, M.A. and Post, R.M. Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychological Medicine, 30(6):1391-1397, 2000.
  13. Depression Guideline Panel. Clinical Practice Guideline. Number 5. Depression in Primary Care: Volume 2. Treatment of Major Depression. Rockville, MD: US Dept. of Health and Human Services, Agency for Health Care Policy and Research. AHCPR Publication No. 93-0551, 1993.
  14. Derogatis, L.R. SCL90 Version Manual 1. Clinical Psychometrics Research Unit, John Hopkins University School of Medicine, Baltimore.
  15. Domkin, M., Scott, J. and Kelly, P. What factors predict discrepancies between self and observer ratings of depression? Journal of Affective Disorders, 31:253-259, 1994.
  16. Dunn, A.L., Trivedi, M.H., Kampert, J.B., Clark, C.G. and Chambliss, H.O. The DOSE study: a clinical trial to examine efficacy and dose response of exercise as treatment for depression. Controlled Clinical Trials, 23(5):584-603, 2002.
  17. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ, for the STAR*D Investigators Group. Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. In Dunner DL, Rosenbaum JF, eds., Psychiatric Clinics of North America. Volume 26. Philadelphia, PA: W.B. Saunders Company, pp. 1-38, 2003.
  18. Fava, M., Alpert, J.E., Carmin, C.N., Wisniewski, S.R., Trivedi, M.H., Biggs, M.M., Shores-Wilson, K., Morgan, D., Schwartz, T., Balasubramani, G.K. and Rush, A.J. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine, 34:1299-1308, 2004.
  19. First, M., Spitzer, R., Gibbon, M., Williams, J. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinical Version. Washington, DC: American Psychiatric Association, 1997.
  20. Gaynes, B.N., Rush, A.J., Trivedi, M., Wisniewski, S.R., Balasubramani, G.K., Spencer, D.C., Petersen, T., Klinkman, M., Warden, D., Schneider, R.K., Castro, D.B. and Golden, R.N. A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial. General Hospital Psychiatry, 27:87-96, 2005.
  21. Gullion, C.M. and Rush, A.J. Toward a generalizable model of symptoms in major depressive disorder. Biological Psychiatry, 44:959-972, 1998.
  22. Hulin, C.L., Drasgow, F., Parsons, C.K. Item Response Theory: Applications to Psychological Measurement. Homewood, IL: Dow Jones Irwin, 1983.
  23. Hamilton, M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23:56-62, 1960.
  24. Hamilton, M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychiatry, 6:278-296, 1967.
  25. Jenkins, C., Carmody, T.J., and Rush, A.J. Depression in radiation oncology patients: A preliminary evaluation. Journal of Affective Disorders, 50:17-21, 1998.
  26. Judd, J., Rapaport, M.H., Yonkers, K.A., Rush, A.J., Frank, E., Thase, M.E., Kupfer, D.J., Plewes, J.M., Schettler, P.J., and Tollefson, G. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. American Journal of Psychiatry, 161:1864-1871, 2004.
  27. Kalpakjian, C.Z., Lam, C.S., and Leahy, B.J. Conceptualization and identification of depression in adults with brain damage by clients and rehabilitation clinical staff. Brain Injury, 16(6):501-507, 2002.
  28. Kashner, T.M., Carmody, T.J., Suppes, T., Rush, A.J., Crismon, M.L., Miller, A.L., Toprac, M., and Trivedi, M. Catching up on health outcomes: the Texas Medication Algorithm Project. Health Services Research, 38(1 Pt 1):311-331, 2003.
  29. Keller, M.B., McCullough, J.P., Klein, D.N., Arnow, B., Dunner, D.L., Gelenberg, A.J., et al. A comparison of nefazodone, the cognitive-behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342:1462-1470, 2000.
  30. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., and Wang, P.S.; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association, 289(23):3095-3105, 2003.
  31. Koran LM, Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, Klein D, Kocsis JH, Schatzberg AF, Thase ME, Rush AJ, Hirschfeld RMA, LaVange LM, Keller MB. Sertraline versus imipramine to prevent relapse in chronic depression. J Affect Disord, 65:27-36, 2001.
  32. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression measure. J Gen Intern Med, 16:603-613, 2001.
  33. Leon AC, Ofson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. In J Psychiatry Med, 27:93-105, 1997.
  34. Leverich,G.S., Nolen, W.A., Rush, A.J., McElroy, S.L., Keck, P.E., Denicoff, K.D., Suppes, T., Altshuler, L.L., Kupka, R., Kramlinger, K.G. and Post R.M. The Stanley Foundation Bipolar Treatment Outcome Network.I. Longitudinal methodology. Journal of Affective Disorders, 67(1-3):33-44, 2001.
  35. Manber, R., Rush, A.J., Thase, M.E., Amow, B., Klein, D., Trivedi, M.H., Korenstein, S.G., Markowitz, J.C., Dunner, D.L., Munsaka, M., Borian, F.E., and Keller, M.B. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. Sleep, 26(2):130-136, 2003.
  36. Mongomery, S.A. and Asberg, M.A. A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134:382-389, 1979.
  37. Nierenberg AA, McLean NE, Alpert JE, Worthington JJ, Rosenbaum JF, Fava M. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry;152:1500-1503, 1995.
  38. Ninan, P.T., Rush, A.J., Crits-Christoph, P., Kornstein, S.G., Manber, R., Thase, M.E., Trivedi, M.H., Rothbaum, B.O., Zajecka, J., Borian, F.E., and Keller, M.B. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Journal of Clinical Psychiatry, 63(5):434-441, 2002.
  39. Perlis, R.H., Fraguas, R., Bankier, B., Fava, M., Trivedi, M., Luther, J.F., Wisniewski, S., Rush, A.J. Prevalence and clinical correlates of irritability in major depressive disorder: A preliminary report from STAR*D. Journal of Clinical Psychiatry, 66(2):159-166, 2005.
  40. Post, R.M., Altshuler, L.L., Frye, M.A., Suppes, T., Rush, A.J., Keck, P.E., McElroy, S.L., Denicoff, K.D., Leverich, G.S., Kupka, R., and Nolen, W.A. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disorders, 3:259-265, 2001.
  41. Quitkin FM, Petkova E, McGrath PJ, Taylor B, Beasley C, Stewart J, Amsterdam J, Fava M, Rosenbaum J, Reimherr F, Fawcett J, Chen Y, Klein D. When should a trial of fluoxetine for major depression be declared failed? Am J Psychiatry;160:734-740, 2003.
  42. Rapaport, M.H., Judd, L.L., Schettler, P.J., Yonkers, K.A., Thase, M.E., Kupfeer, D.J., Frank, E., Plewes, J.M., Tollefson, G.D., and Rush, A.J. A descriptive analysis of minor depression. American Journal of Psychiatry, 159:637-643, 2002.
  43. Rush, A.J., Bernstein, I.H., Trivedi, M.H., Carmody, T.J., Wisniewski, S., Mundt, J.C., Shores-Wilson, K., Biggs, M.M., Nierenberg, A.A., Fava, M.F. An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression Trial report. Biological Psychiatry, 59(6):493-501, 2006.
  44. Rush, A.J., Carmody, T. and Reimitz, P.E. The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. International Journal of Methods in Psychiatric Research, 9:45-59, 2000.
  45. Rush, A.J., Bernstein, I.H., Trivedi, M.H., Carmody, T.J., Wisniewski, S., Mundt, J.C., Shores-Wilson, K., Biggs, M.M., Nierenberg, A.A., Fava, M.F. An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression trial report. Biological Psychiatry, in press.
  46. Rush, A.J., Carmody T.J., Ibrahim H.M., Trivedi M.H., Biggs M.M., Shores-Wilson K., Crismon, M.L., Toprac M.G., and Kashner T.M. Do self-report ratings of depression compare favorably to clinician ratings in public sector patients? Manuscript in preparation, available upon request.
  47. Rush, A.J., Gullion, C.M., Basco, M.R., Jarrett, R.B. and Trivedi, M.H. The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychological Medicine, 26:477-486, 1996.
  48. Rush, A.J., Carmody, T. and Reimitz, P.E. The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. International Journal of Methods in Psychiatric Research, 9:45-59, 2000.
  49. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart J, McGrath PJ, Biggs MM, Shores-Wilson K, O’Neal BL, Lebowitz BD, Ritz L, Niederehe G, for the STAR*D Investigators Group. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Rationale and design. Controlled Clinical Trials, 25:119-142, 2004.
  50. Rush, A.J., Giles, D.E., Schlesser, M.A., Fulton, C.L.,Weissenburger, J.E. and Burns, C.T. The Inventory of Depressive Symptomatology (IDS): Preliminary findings. Psychiatry Research, 18:65-87, 1986.
  51. Rush, A.J., Gullion, C.M., Basco, M.R., Jarrett, R.B. and Trivedi, M.H. The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychological Medicine, 26:477-486, 1996.
  52. Rush, A.J., Hiser, W. and Giles, D.E. A comparison of self-reported versus clinician-rated symptoms in depression. Journal of Clinical Psychiatry, 48:246-248, 1987.
  53. Rush, A.J., Trivedi, M.H., Carmody, T.J., Biggs, M.M., Shores-Wilson, K., Ibrahim, H., and Crismon, M.L. One-year clinical outcomes of depressed public-sector outpatients: A benchmark for subsequent studies. Biological Psychiatry, 56:46-53, 2004.
  54. Rush, A.J., Trivedi, M.H., Carmody, T.J., Ibrahim, H.M., Markowitz, J.C., Keitner, G.I., Kornstein, S.G., Arnow, B., Klein, D.N., Manber, R., Dunner, D.L., Gelenberg, A.J., Kocsis, J.H., Nemeroff C.B., Fawcett, J., Thase, M.E., Russell, J.M., Jody, D.N., Borlan, F.E., Keller, M.B. Self-reported depressive symptom measures: Sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology, 30:405-416, 2005.
  55. Rush, A.J., Trivedi, M.H., Carmody, T.J., Ibrahim, H.M., Markowitz, J.C., Keitner, G.I., Kornstein, S.G., Arnow, B., Klein, D.N., Manber, R., Dunner, D.L., Gelenberg, A.J., Kocsis, J.H., Nemeroff C.B., Fawcett, J., Thase, M.E., Russell, J.M., Jody, D.N., Borlan, F.E., Keller, M.B. Self-reported depressive symptom measures: Sensitivity to detecting 7change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology, 30:405-416, 2005.
  56. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54:573-583, 2003.
  57. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54:573-583, 2003.
  58. Schulberg HC, Katon W, Simon GE, Rush AJ. Treating major depression in primary care practice: An update of the Agency for Health Care Policy and Research practice guidelines. Arch Gen Psychiatry, 55:1121-1127, 1998.
  59. Suppes, T., Chisholm, K.A., Dhavale, D., Frye, M.A., Altshuler, L.L., McElroy, S.L., Keck, E., Nolen, W.A., Kupka, R., Denicoff, K.D., Leverich, G.S., Rush, A.J., and Post, R.M. Tiagabine in treatment refractory bipolar disorder: a clinical case series. Bipolar Disorder, 4: 283-289, 2002.
  60. Surís, A., Kashner, T.M., Gillaspy, J.A., Jr., Biggs, M. and Rush, A.J. Validation of the Inventory of Depressive Symptomatology (IDS) in cocaine dependent inmates. Journal of Offender Rehabilitation, 32:15-30, 2001.
  61. Tondo, L., Burrai, C., Scamonatti, L., Weissenburger, J.E. and Rush, A.J. A comparison between clinician-rated and self-reported depressive symptoms in Italian psychiatric patients. Neuropsychobiology, 19:1-5, 1988.
  62. Trivedi, M.H., Rush, A.J., Crismon, M.L., Kashner, T.M., Toprac, M.G., Carmody, T.J., Key, T., Biggs, M.M., Shores-Wilson, K, Whitte, B., Suppes, T., Miller, A.L., Altshuler, K.Z., and Shon, S.P. Clinical results for the patient with major depressive disorder in the Texas Medication Algorithm Project. Archives of General Psychiatry, 61:669-679, 2004.
  63. Trivedi, M.H., Rush, A.J., Ibrahim, H.M., Carmody, T.J., Biggs, M.M., Suppes, T., Crismon, M.L., Shores-Wilson, K., Toprac, M.G., Dennehy, E.B., Whitte, B., and Kashner, T.M. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), the Quick Inventory of Depressive Symtomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine, 34:73-82, 2004.
  64. Trivedi, M.H., Rush, A.J., Ibrahim, H.M., Carmody, T.J., Biggs, M.M., Suppes, T., Crismon, M.L., Shores-Wilson, K., Toprac, M.G., Dennehy, E.B., Whitte, B., and Kashner, T.M. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), the Quick Inventory of Depressive Symtomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine, 34:73-82, 2004.
  65. Trivedi, M.H., Rush, A.J., Pan, J.Y and Carmody, T.J. Which depressed patients respond to nefazodone and when? Journal of Clinical Psychiatry, 62(3):158-163, 2001.
  66. Tsevat, J., Keck, P.E., Hornung, R.W., and McElroy, S.L. Health values of patients with bipolar disorder. Quality of Life Research, 9(5):579-586, 2000.
  67. Ware, J.E., Kosinske, M. and Keller, S.D. A 12-item short-form health survey (SF-12): construction of scales and preliminary tests of reliability and validity. Medical Care, 34: 220-233, 1996.
  68. Yates, W.R., Mitchell, J., Rush, A.J., Trivedi M., Wisniewski, S., Warden, D., Hauger, R.B., Fava, M., Gaines, B.N., Husain, M., and Bryan, C. Clinical features of depressed outpatients with and without general medical conditions in STAR*D. General Hospital Psychiatry, 26(6):421-429, 2004.
  69. Yonkers, K.A., Ramin, S.M., Rush, A.J., Navarrete, C.A., Carmody, T., March, D., Heartwell, S.F. and Leveno, K.J. Onset and persistence of postpartum depression in an inter-city maternal health clinical system. American Journal of Psychiatry, 158(11):1856-1863, 2001.
  70. Zisook, S., Rush, A.J., Albala, A., Alpert, J., Balasubramani, G.K., Fava, M., Husain, M., Sackeim, H., Trivedi, M. and Wisniewski, S. Factors that differentiate early vs. later onset of major depressive disorder. Psychiatry Research, 129(2):127-140, 2004.
  71. Zung, W.W.K. A self-rating depression scale. Archives of General Psychiatry, 12:63-70, 1965.